News & Articles

356-patient concordance study confirms performance using head-to-head testing vs. droplet digital PCR

Top talks presenting the latest technologies, research and applications are now available on demand

Real-world data demonstrated 92% vaccine effectiveness against hospitalisations due to the Delta variant

Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative

This multi-session event will take you on a weekly path of discovery, featuring the latest in IHC antibodies, histology troubleshooting techniques, case studies in pathology, and more

Novel chip-based diagnostic technology can detect individual viral antigens in nasal swab samples to identify the viruses that cause COVID-19 and flu with a single test

The test will be widely available to individuals through pharmacies and other locations in accordance with local guidelines and testing strategies

Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India

Guest editorial: Learn how clinicians can utilize diagnostic information to make decisions when examining suspected SARS-CoV-2 patients

The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)

From its expedited development to its far-reaching adoption, COVID-19 antigen testing is helping students and workforces safely return to daily life

Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D

Company’s RT-PCR kits and workflow solutions will continue to safeguard capacity for NHS Test and Trace laboratory

The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples

New findings pave way to potentially improved assessment of measurable residual disease in AML patients

The Allplex SARS-CoV-2 Master Assay can detect a total of 10 targets including four coronavirus genes

Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min

Dr. Boye Schnack Nielsen shares tips for running successful in situ hybridization assays as he provides insights on how RNA detection methods have evolved over time

Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month